1. Home
  2. PLNT vs CORT Comparison

PLNT vs CORT Comparison

Compare PLNT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Fitness Inc.

PLNT

Planet Fitness Inc.

HOLD

Current Price

$49.10

Market Cap

4.2B

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$110.60

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PLNT
CORT
Founded
1992
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
9.7B
IPO Year
2015
2001

Fundamental Metrics

Financial Performance
Metric
PLNT
CORT
Price
$49.10
$110.60
Analyst Decision
Strong Buy
Buy
Analyst Count
13
5
Target Price
$107.46
$96.50
AVG Volume (30 Days)
2.2M
1.3M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
$1,324,144,000.00
$761,407,000.00
Revenue This Year
$19.22
$26.08
Revenue Next Year
$11.66
$26.98
P/E Ratio
$38.47
$1,246.44
Revenue Growth
12.06
12.79
52 Week Low
$37.03
$28.66
52 Week High
$114.26
$122.21

Technical Indicators

Market Signals
Indicator
PLNT
CORT
Relative Strength Index (RSI) 36.47 62.28
Support Level $37.03 $76.41
Resistance Level $54.47 $122.21
Average True Range (ATR) 1.80 5.00
MACD -0.84 -0.03
Stochastic Oscillator 14.46 65.76

Price Performance

Historical Comparison
PLNT
CORT

About PLNT Planet Fitness Inc.

Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: